MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.autrev.2022.103133

Медицинская библиотека · Autoimmunity reviews · 2022

Clinical impact and prognosis of cryoglobulinemia and cryofibrinogenemia in systemic sclerosis.

De Almeida Chaves Sébastien, Puissant Bénédicte, Porel Tiphaine, Bories Eva, Adoue Daniel, Alric Laurent, Astudillo Léonardo, Huart Antoine, Lairez Olivier, Michaud Martin, Ribes David, Prévot Grégoire, Sailler Laurent, Gaches Francis, Pugnet Gregory

СтатьяОбзорПеревод в очереди

Аннотация

INTRODUCTION

An association of systemic sclerosis (SSc) with cryoglobulin and/or cryofibrinogenemia has been described. However, clinical, biological, morphological and prognostic implications are unknown. The objective of this study was to describe the phenotype and evaluate the prognosis of cryoglobulinemia and/or cryofibrinogenemia in the progression of SSc.

MATERIALS AND

METHODS

Patients were included from the Systemic Scleroderma Toulouse Cohort (SSTC), between June 1, 2005 and May 31, 2018, and underwent a measurement of a cryoglobulin and/or cryofibrinogen in immunology laboratory at the Toulouse University Hospital Center. Patients with and without cryoglobulinemia >50 mg/l and patients with and without cryofibrinogenemia were compared to identified the impact of cryoprcipitate on the phenotype. Mortality based on cryoprecipitate was explored.

RESULTS

166 patients were included in the study. 43.3% and 46.6% had a cryoglobulinemia >50 mg/l and cryofibrinogenemia, respectively. Cryoglobulin >50 mg was not associated with microvascular damage. Cryoglobulin does not influence the phenotype. 5-and 10-years survival were 97.6% and 88.8% respectively in patients with cryoglobulinemia >50 mg/l versus 91.9% and 78.4% in patients without cryoglobulin>50 mg/l. 10-years survival was better for patients with cryoglobulinemia >50 mg/l (log-rank 0.0363). Cryofibrinogenemia was not associated with neoplasia, any clinical (in particular ischemic damage), biological or morphological features. Cryofibrinogenemia had no influence on the mortality of these patients.

CONCLUSION

Cryoglobulinemia and cryofibrinogenemia are frequent in SSc. The presence of cryoprecipitate (cryoglobulin or cryofibrinogen) not influence the phenotype and has not associated with a poor survival.

Для цитирования: De Almeida Chaves Sébastien, Puissant Bénédicte, Porel Tiphaine, Bories Eva, Adoue Daniel, Alric Laurent, Astudillo Léonardo, Huart Antoine, Lairez Olivier, Michaud Martin, Ribes David, Prévot Grégoire, Sailler Laurent, Gaches Francis, Pugnet Gregory. Clinical impact and prognosis of cryoglobulinemia and cryofibrinogenemia in systemic sclerosis.. Autoimmunity reviews. 2022. DOI: 10.1016/j.autrev.2022.103133.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.